BCRX

BioCryst Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$9.02

Market Cap

$1.89B

Beta

0.76

P/E

8.2

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+94.10%

EPS Growth (YoY)+378.77%

Revenue CAGR 3Y+47.82%

P/E Ratio8.2

PEG Ratio0.02

FCF Yield+17.35%

Debt / Equity0.00

Interest Coverage4.3x

No credit card required

Already have an account? Sign in to view the full analysis for BCRX.